LINC02012

Across TCGA pan-cancer cohorts, LINC02012 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC02012’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02012 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02012 is over-expressed in tumor, although a few such as COAD and KIRC show the opposite, repressed pattern.

COAD, KIRC, and LIHC are the cancer types where LINC02012 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02012 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	All	−1.000	<.001	11	view →
KIRC	Male	II,III,IV	−0.904	<.001	9	view →
LIHC	Male	All	+0.792	<.001	8	view →
THCA	Male	All	−0.725	<.001	8	view →
LUSC	All	All	+1.074	<.001	7	view →
KIRP	All	II,III,IV	−0.561	.002	6	view →
UCEC	All	All	+0.966	<.001	4	view →
LUAD	All	All	+0.267	<.001	4	view →
BRCA	All	All	+0.224	<.001	4	view →
READ	All	All	−0.774	.026	3	view →
BLCA	All	All	+0.590	.027	3	view →
PRAD	All	All	+0.535	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC02012–COAD

Open the COAD breakdown →